This new report from PwC’s Health Research Institute (HRI), The FDA and industry: a recipe for collaborating in the New Health Economy, shows a strong focus by consumers and insurers on cost-effectiveness as well as medical benefit will increase pressures on the FDA to consider similar changes. See more here. (Source: Laura Joszt, AJMC Managed Markets Network, 1/26/15)
Connected. Community.
